PharmaTher Holdings (XCNQ:PHRM) Cash And Cash Equivalents : C$2.43 Mil (As of Feb. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Cash And Cash Equivalents?

PharmaTher Holdings's quarterly cash and cash equivalents declined from Aug. 2023 (C$4.27 Mil) to Nov. 2023 (C$3.15 Mil) but then stayed the same from Nov. 2023 (C$3.15 Mil) to Feb. 2024 (C$2.43 Mil).

PharmaTher Holdings's annual cash and cash equivalents increased from May. 2021 (C$2.78 Mil) to May. 2022 (C$9.16 Mil) but then declined from May. 2022 (C$9.16 Mil) to May. 2023 (C$5.92 Mil).

PharmaTher Holdings Cash And Cash Equivalents Historical Data

The historical data trend for PharmaTher Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Cash And Cash Equivalents Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

Cash And Cash Equivalents

2.78

9.16

5.92

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Cash And Cash Equivalents	Get a 7-Day Free Trial										6.64	5.92	4.27	3.15	2.43

PharmaTher Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

PharmaTher Holdings (XCNQ:PHRM) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

PharmaTher Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings (XCNQ:PHRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

PHRRF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.

Executives

Fabio Chianelli

Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines